Persistent Systems Invests in DxNow

Persistent Systems Invests in DxNow 
Boston-Based Life Sciences Start-Up Second Recipient of Persistent
Venture Fund 
PUNE, INDIA and SANTA CLARA, CA and BOSTON, MA -- (Marketwired) --
12/18/13 --  Persistent Systems (BOMBAY: PERSISTENT) (NSE:
PERSISTENT), the global leader in software product and technology
services, today announced that it has invested in DxNow, a privately
held Boston company that is developing advanced micro-fluidic and
imaging technologies for point-of-care diagnostic solutions. DxNow is
the second recipient to receive seed money from the Persistent
Venture Fund, an early-stage investment fund announced last month,
focused on supporting innovation in areas of Persistent's expertise
and involving social, mobile, analytics and cloud computing (SMAC)
technologies.  
DxNow products and technologies will be initially applied to
infection detection in renal dialysis patients and will subsequently
address applications in forensics, male fertility, global health and
rapid detection of microbial species in the environment to ensure
public health and safety. The product related to dialysis, the DxNow
Infection Detection System(TM), will be a simple-to-use micro-fluidic
device that enables early detection of infection in peritoneal
dialysis (PD) patients, before the infection has serious health
impacts. The system will alert patients and caregivers simultaneously
when an infection is detected via easy to use enabling technology
that allows for timely clinical intervention -- reducing the need for
costly emergency room visits and hospitalization. DxNow will use
mobility and cloud computing to help ensure timely, accurate and
effective monitoring for the onset of infection -- critical to
reducing costs and improving patient outcomes. 
"Today there are approximately 300,000 PD patients worldwide and that
number is expected to grow to more than 400,000 in the next four
years," said William T. Sharp, CEO, DxNow. "Our goal is to provide a
device that delivers better patient outcomes, and reduced costs and
complications, as well as peace of mind for PD patients and their
caregivers by enabling early clinical intervention when infection is
detected. Persistent Systems expertise in life sciences as well as
mobile and cloud computing make them an ideal partner." 
"DxNow is providing an innovative solution to a critical problem,
reducing the current time of infection detection from days to minutes
with greater accuracy," said Dr. Sridhar Jagannathan, Chief
Innovation Officer, Persistent Systems, Inc. "Our investment in DxNow
draws on Persistent's significant expertise in medical technologies
and life sciences. We look forward to advantaging DxNow in their
journey to creating breakthrough products and saving lives." 
For additional information on the Persistent Venture Fund, please
email info@persistentsys.com. 
About DxNow:
 DxNow is a privately held company located in the Boston
area leveraging advanced microfluidic and imaging technologies for
point-of-care diagnostic solutions. DxNow products and technologies
will be applied to applications in dialysis, male fertility, global
health, and rapid detection of microbial species in the environment,
contributing to public safety and health in the applied life
sciences. For more information, please visit:
http://www.dxnowinc.com. 
About Persistent Systems:
 Persistent Systems (BOMBAY: PERSISTENT)
(NSE: PERSISTENT) is a global company specializing in software
product and technology services. For over two decades, Persistent has
consistently been selected as the trusted innovation partner for the
world's largest technology brands, leading enterprises and pioneering
start-ups. Persistent has a global team of more than 7,000 employees
worldwide including offices and delivery centers in North America,
Europe and Asia-Pacific. Persistent develops best-in-class solutions
in key next-generation technology areas including Analytics, Big
Data, Cloud Computing, Mobility and Social, for the
telecommunications, life sciences, healthcare and banking & financial
services verticals. For more information, please visit:
http://www.persistent.com.  
All trademarks, trade names, service marks, and logos referenced
herein belong to their respective companies. 
Media contacts:
Rashmi Joshi
Persistent Systems Ltd.
Tel: 91 83083 39400 
Email: rashmi_joshi@persistent.co.in  
Ilona Mohacsi
PenVine
Tel: +16317643729
Email: ilona@penvine.com 
For DxNow, Inc.:
Ryan Ferrell
Harris D. McKinney
Mobile: 312 208 8600
Email: rferrell@harrisdmckinney.com 
 
 
Press spacebar to pause and continue. Press esc to stop.